Chronic Disease

2
Pipeline Programs
4
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
3 programs
1
1
morphine sulfate and naltrexone hydrochloridePhase 41 trial
GH treatmentPhase 31 trial
Hospital-Based Vaccination PathwayN/A1 trial
Active Trials
NCT07391046Not Yet Recruiting1,500Est. Feb 2027
NCT00813189Completed30Est. May 2012
NCT01179191Terminated684Est. Apr 2011
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Biospecimen CollectionN/A1 trial
Active Trials
NCT04160429RecruitingEst. Jul 2029
Concerto Biosciences
Concerto BiosciencesMA - Cambridge
1 program
Concerto+N/A1 trial
Active Trials
NCT03628963Unknown200Est. Nov 2019
Francis Medical
Francis MedicalMN - Maple Grove
1 program
Conversation card gameN/A1 trial
Active Trials
NCT02619370CompletedEst. Sep 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Pfizermorphine sulfate and naltrexone hydrochloride
PfizerGH treatment
PfizerHospital-Based Vaccination Pathway
City TherapeuticsBiospecimen Collection
Concerto BiosciencesConcerto+
Francis MedicalConversation card game

Clinical Trials (6)

Total enrollment: 2,414 patients across 6 trials

NCT01179191Pfizermorphine sulfate and naltrexone hydrochloride

Conversion to Embeda With Rescue Trial

Start: Aug 2010Est. completion: Apr 2011684 patients
Phase 4Terminated
NCT00813189PfizerGH treatment

Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid

Start: Apr 2005Est. completion: May 201230 patients
Phase 3Completed
NCT07391046PfizerHospital-Based Vaccination Pathway

Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients

Start: Feb 2026Est. completion: Feb 20271,500 patients
N/ANot Yet Recruiting
NCT04160429City TherapeuticsBiospecimen Collection

Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations

Start: Nov 2018Est. completion: Jul 2029
N/ARecruiting
NCT03628963Concerto BiosciencesConcerto+

Optimizing Patient Usability Experience for Chronic Care

Start: Sep 2018Est. completion: Nov 2019200 patients
N/AUnknown
NCT02619370Francis MedicalConversation card game

Evaluation of an Advance Care Planning Activity: Feasibility Testing for a Randomized Controlled Trial

Start: Jan 2016Est. completion: Sep 2016
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 2,414 patients
4 companies competing in this space